INDUSTRIALIZATION OF DRUG DISCOVERY FROM TARGET SELECTION THROUGH LEAD OPTIMIZATION (PB 2019)
Language: English
Published by TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2019
- Softcover
- New

Seller: UK BOOKS STORE, London, London, United KingdomUK BOOKS STORE
AbeBooks seller since March 11, 2024
Condition: New
US$ 130.04
Quantity: 18 available
Add to basketItem description from seller
Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Seller Inventory # CvS 9781032099941
- Title
- INDUSTRIALIZATION OF DRUG DISCOVERY FROM TARGET SELECTION THROUGH LEAD OPTIMIZATION (PB 2019)
- Author
- HANDEN J.S.
- Publisher
- TAYLOR & FRANCIS NP EXCLUSIVE(CBS)
- Publication year
- 2019
- Condition
- New
- Binding
- Soft cover
- Language
- English
- ISBN 10
- 1032099941
- ISBN 13
- 9781032099941
- Edition
- International Edition
- Series
- Book 4 of 7: Drug Discovery Series
The drug discovery and development process is getting longer, more expensive, and no better. The industry suffers from the same clinical attrition and safety-related market withdrawal rates today as it did 20 years ago. Industrialization of Drug Discovery: From Target Selection Through Lead Optimization scrutinizes these problems in detail, contrasting the promise of technology and industrialization with the challenges of using the tools available to their best advantage. The book explores early successes, examines the current state of the art, and provides a strategic analysis of the issues currently facing drug discovery.
Introducing the historical background and current status of the industry, the book delineates the basic tenets underlying modern drug discovery, how they have evolved, and their use in various approaches and strategies. It examines, in detail, the regulations, requirements, guidelines, and draft documents that guide so many FDA actions. The editor devotes the remainder of the discussion to industrialization, compound and knowledge management functions, the drug screening process, collaboration, and finally, ethical issues.
Drawing on real-life, from-the-trenches examples, the book elucidates a new approach to drug discovery and development. This modern-day, back-to-basics approach includes three steps: understand the science, unravel the story, and then intelligently apply the technology, bringing to bear the entire armamentarium of industrialization techniques, not just automation, to the discovery process. Using these steps, you can meet the goals of more specific targets, more selective compounds, and decreased cycle times. In effect, you can look for a bigger needle in a smaller haystack.
Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.
"Synopsis" may belong to another edition of this title.
About the Author
"About the title" may belong to another edition of this title.
UK BOOKS STORE
London, London, United Kingdom
AbeBooks seller since March 11, 2024
Shipping rates from United Kingdom to U.S.A.
| Item | 5 to 10 business days | 4 to 7 business days |
|---|---|---|
| First item | US$ 5.27 | US$ 11.74 |
Payment methods
Seller's business information
URBAN BOOK LIMITED
71-75 Shelton Street, Covent Garden
London, United Kingdom WC2H 9JQ